Company intelligence / Profile preview

Ross, Dixon & Bell

Washington, DC, USA

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Ross, Dixon & Bell was a prominent American law firm founded in 1983 and headquartered in Washington, D.C., with additional offices in California and Chicago. The firm specialized in complex commercial litigation, antitrust, and insurance coverage, with a significant focus on the life sciences and biotechnology industries. It was notably involved in pharmaceutical legal matters, including patent settlement disputes under the Hatch-Waxman Act and insurance risk management for biotech entities. In 2009, the firm merged with Troutman Sanders, and its practice groups were integrated into what is now the international law firm Troutman Pepper. The firm's legacy includes high-profile representation of insurers and participation in congressional hearings regarding pharmaceutical competition.

Industry: Consulting

Beyond the preview

Go deeper on Ross, Dixon & Bell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ross, Dixon & Bell.

Explore the full profile